chrX-154460301-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_017514.5(PLXNA3):c.118C>T(p.Arg40Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,208,376 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 25)
Exomes 𝑓: 0.000035 ( 0 hom. 9 hem. )
Consequence
PLXNA3
NM_017514.5 missense
NM_017514.5 missense
Scores
6
8
Clinical Significance
Conservation
PhyloP100: 1.14
Genes affected
PLXNA3 (HGNC:9101): (plexin A3) This gene encodes a member of the plexin class of proteins. The encoded protein is a class 3 semaphorin receptor, and may be involved in cytoskeletal remodeling and as well as apoptosis. Studies of a similar gene in zebrafish suggest that it is important for axon pathfinding in the developing nervous system. This gene may be associated with tumor progression. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 9 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLXNA3 | NM_017514.5 | c.118C>T | p.Arg40Trp | missense_variant | 2/33 | ENST00000369682.4 | NP_059984.3 | |
PLXNA3 | XM_047442247.1 | c.118C>T | p.Arg40Trp | missense_variant | 2/22 | XP_047298203.1 | ||
PLXNA3 | XR_007068193.1 | n.293C>T | non_coding_transcript_exon_variant | 2/32 | ||||
PLXNA3 | XR_430556.4 | n.293C>T | non_coding_transcript_exon_variant | 2/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLXNA3 | ENST00000369682.4 | c.118C>T | p.Arg40Trp | missense_variant | 2/33 | 1 | NM_017514.5 | ENSP00000358696.3 | ||
PLXNA3 | ENST00000495040.1 | n.146-798C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000891 AC: 1AN: 112210Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 34380
GnomAD3 genomes
AF:
AC:
1
AN:
112210
Hom.:
Cov.:
25
AF XY:
AC XY:
0
AN XY:
34380
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000221 AC: 4AN: 180679Hom.: 0 AF XY: 0.0000302 AC XY: 2AN XY: 66205
GnomAD3 exomes
AF:
AC:
4
AN:
180679
Hom.:
AF XY:
AC XY:
2
AN XY:
66205
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000347 AC: 38AN: 1096166Hom.: 0 Cov.: 31 AF XY: 0.0000249 AC XY: 9AN XY: 361966
GnomAD4 exome
AF:
AC:
38
AN:
1096166
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
361966
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000891 AC: 1AN: 112210Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 34380
GnomAD4 genome
AF:
AC:
1
AN:
112210
Hom.:
Cov.:
25
AF XY:
AC XY:
0
AN XY:
34380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PLXNA3-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 14, 2024 | The PLXNA3 c.118C>T variant is predicted to result in the amino acid substitution p.Arg40Trp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0063% of alleles in individuals of European (Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Benign
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Benign
D
Sift4G
Uncertain
D
Vest4
MutPred
Gain of catalytic residue at R40 (P = 0.0415);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at